Dependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling schedule
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dependence of treatment planning accuracy in peptide receptor radionuclide therapy on the sampling schedule
Authors
Keywords
Physiologically based pharmacokinetic (PBPK) modeling, Peptide receptor radionuclide therapy (PRRT), Optimal sampling schedule, Neuroendocrine tumor (NET), Time-integrated activity coefficient (TIAC)
Journal
EJNMMI Research
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-25
DOI
10.1186/s13550-016-0185-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population-Based Modeling Improves Treatment Planning Before90Y-Labeled Anti-CD66 Antibody Radioimmunotherapy
- (2015) Christian Maaß et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with 131 I-metaiodobenzylguanidine with implications for the activity to administer
- (2015) Pablo Mínguez et al. MEDICAL PHYSICS
- Pharmacokinetic digital phantoms for accuracy assessment of image-based dosimetry in177Lu-DOTATATE peptide receptor radionuclide therapy
- (2015) Gustav Brolin et al. PHYSICS IN MEDICINE AND BIOLOGY
- The NUKDOS software for treatment planning in molecular radiotherapy
- (2015) Peter Kletting et al. Zeitschrift fur Medizinische Physik
- Physiologically Based Pharmacokinetic Modeling Is Essential in 90Y-Labeled Anti-CD66 Radioimmunotherapy
- (2015) Peter Kletting et al. PLoS One
- The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy
- (2014) Lidia Strigari et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Design and clinical implementation of a 99mTc-HYNICTOC-based dosimetric protocol in PRRT of NETs with 90Y-DOTATOC
- (2014) M.T. Chalkia et al. Physica Medica-European Journal of Medical Physics
- Population Pharmacokinetics and Bayesian Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients: Comparison of Two Approaches
- (2013) R. Youdarene et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Comparison of an assumption-free Bayesian approach with Optimal Sampling Schedule to a maximum a posteriori Approach for Personalizing Cyclophosphamide Dosing
- (2013) José M. Laínez et al. PHARMACOTHERAPY
- Treatment planning in molecular radiotherapy
- (2013) Gerhard Glatting et al. Zeitschrift fur Medizinische Physik
- 111In-DTPA0-octreotide (Octreoscan), 131I-MIBG and other agents for radionuclide therapy of NETs
- (2012) Jamshed B. Bomanji et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Differences in predicted and actually absorbed doses in peptide receptor radionuclide therapy
- (2012) Peter Kletting et al. MEDICAL PHYSICS
- Optimisation of sampling windows design for population pharmacokinetic experiments
- (2008) Kayode Ogungbenro et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Application of optimal design methodologies in clinical pharmacology experiments
- (2008) Kayode Ogungbenro et al. PHARMACEUTICAL STATISTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started